Show simple item record

dc.contributor.advisorWoods, Robert
dc.contributor.advisorWoods, Robert
dc.contributor.authorWalsh, Niall
dc.date.accessioned2014-10-29T17:19:34Z
dc.date.issued2014-10-21
dc.identifier.urihttp://hdl.handle.net/10379/4683
dc.description.abstractHeparan Sulphate (HS) is a highly charged glycosyaminoglycan (GAG) that is closely related to Heparin, a related GAG with a higher degree of sulphation. Heparin is used in the development of anticoagulant drugs. Currently, there is a lack of useful reagents for studying and distinguishing between complex GAGs like heparin/heparan sulphate from other GAGs. As a result, GAGs are often contaminated with other GAGs like chondroitin sulphate upon isolation. To improve GAG characterization, we aim to engineer a heparin reagent through the conversion of the HS modifying enzyme 3-O-sulphotransferase isoform 1 (3-OST-1). 3-OST-1 transfers a sulphate group to the 3-OH position of an N-sulpho-glucosamine linked to a glucuronic acid. This modification is essential for heparin used in the development of anticoagulant drugs like Arixtra. Four 3-OST-1 mutants, E90Q, E90K, E90H and E90R were generated using site-directed mutagenesis. The binding affinity for 3-OST-1 modified heparin was measured by surface plasmon resonance using the anticoagulant drug Arixtra. The effect of side chain and charge at position 90 among the four mutants in binding to Arixtra was investigated. The mutant with the greatest binding affinity was determined. Here in is the report on the expression, purification and binding analysis of the mutants to date.en_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectProtein expressionen_US
dc.subjectSPRen_US
dc.subject3-O-sulphotransferase 1en_US
dc.subjectHeparinen_US
dc.subjectSchool of Chemistryen_US
dc.titleRecombinant expression and characterization of ligand binding to mutants ff 3-O-sulphotransferase-1en_US
dc.typeThesisen_US
dc.local.noteHeparin is an anticoagulant drug derived from natural sources, typically porcine intestine. There are currently few ways of characterizing heparin and few ways of distinguishing heparin from similar molecules. To improve heparin characterization, we aim to engineer a heparin reagent through the conversion of the HS modifying enzyme 3-O-sulphotransferase isoform 1 (3-OST-1). Here in is the report on the expression, purification and binding analysis of the reagent to date.en_US
dc.description.embargo2016-10-17
dc.local.finalYesen_US
nui.item.downloads783


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland